Cigna Group Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Cigna Group (NYSE:CI) reported its Q2 2025 results with revenues of $67.2 billion, an 11% increase from Q2 2024, exceeding expectations by 7.2%. However, net income fell 1% to $1.53 billion, and EPS of $5.76 missed estimates by 2.1%. The profit margin decreased to 2.3% due to higher expenses. Revenue is projected to grow 4.5% annually over the next three years, below the 6.0% growth forecast for the US Healthcare industry. Cigna's shares have dropped 12% in the past week, and there is one warning sign to consider.
Cigna Group (NYSE:CI) Second Quarter 2025 Results
Key Financial Results
- Revenue: US$67.2b (up 11% from 2Q 2024).
- Net income: US$1.53b (down 1.0% from 2Q 2024).
- Profit margin: 2.3% (down from 2.6% in 2Q 2024). The decrease in margin was driven by higher expenses.
- EPS: US$5.76.
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Cigna Group Revenues Beat Expectations, EPS Falls Short
Revenue exceeded analyst estimates by 7.2%. Earnings per share (EPS) missed analyst estimates by 2.1%.
Looking ahead, revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 6.0% growth forecast for the Healthcare industry in the US.
Performance of the American Healthcare industry.
The company's shares are down 12% from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 1 warning sign for Cigna Group you should be aware of.
